Staples: Analysts' Upgrades, Downgrades

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Amedisys (AMED Quote) downgraded at UBS. Rating lowered to Neutral from Buy. Maintains $46 price target and 2009 EPS estimates of $4.57.

Affiliated Managers (AMG Quote) upgraded at Credit Suisse from Neutral to Outperform. Estimates also boosted, to reflect an expected turnaround in asset inflows. Company may also be looking at accretive acquisitions. $69 price target.

Buffalo Wild Wings (BWLD Quote) initiated at Jesup & Lamont with a Buy rating and $49 price target. Introduces 2009 estimates of $1.70.

Comcast (CMCSA Quote) initiated at JP Morgan with an Overweight rating with a $19 price target. Introduces 2009 EPS estimates of $1.09.

Fiserv (FISV Quote) rated new Buy at Citigroup. $57 price target. Company is seeing internal growth recover and has positive operating leverage.

General Maritime (GMR Quote) upgraded at FBR from Market Perform to Outperform. $9 price target. Dividend reduction should allow the company to buy vessels near trough valuations.

Deltek (PROJ Quote) upgraded at Barclays to Overweight from Equal Weight on leverage to recovery. 2009 and 2010 EPS estimates cut from $0.54 to $0.52 and from $0.56 to $0.54, respectively. Price target raised to $10 from $7.

St. Jude Medical (STJ Quote) upgraded at Wells Fargo to Outperform. ICD market should accelerate in 2010 and the stock is trading at a compelling valuation.

Time Warner Cable (TWC Quote) initiated at JPMorgan. Initiated with an Overweight rating and $45 price target. Introduces 2009 EPS estimates of $2.99.

Wabtec (WAB Quote) upgraded at Longbow from Neutral to Buy. $45 price target. New survey suggests that earnings should bottom out in 2009.

STOCK COMMENTS / EPS CHANGES

Corinthian Colleges (COCO Quote) numbers increased at Merrill/BofA. Price target to $24 from $22 after COCO 's 4Q results beat expectations. 2010 and 2011 EPS estimates set at $1.34 and $1.71, respectively. Reiterate But rating.

Corinthian Colleges (COCO Quote) price target raised at Barclays to $26 from $25 on belief that shares are too cheap. 2010 EPS estimate lifted to $1.35 from $1.19 and 2011 EPS estimate set at $1.61. Maintain Overweight rating.